Fitabase CEO Aaron Coleman said he sees the integration being particularly useful to researchers looking at how behavioral recommendations in areas like physical activity and sleep can affect glucose levels to create more tailored care plans for diabetic patients.
The company is pursuing its own clinical trials with the University of Kansas to prove out healthcare capabilities in conditions like sleep apnea and atrial fibrillation detection.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Ernesto Ramirez, the new head of research and development at Fitabase, said that the wearable fitness gadgets are only now starting to realize their potential.
Fitabase, made by San Diego-based startup Small Steps Labs, has now collected more than 2 billion minutes of Fitbit data for research purposes.